ChemRegen Inc is a biotechnology company located in San Diego, CA, specializing in cardiac regeneration and the treatment of breast and colorectal cancer. Situated in close proximity to renowned research institutions such as the University of California, San Diego, The Salk Research Institute, The Sanford-Burnham Medical Research Institute, and The Scripps Research Institute, ChemRegen benefits from a vibrant scientific community. With its strategic location in the Golden Triangle and BioTech Beach, the company is conveniently accessible to over 25,000 researchers in academic institutions and biotechnology companies within a short drive.
Offering cutting-edge research technology, ChemRegen has gained recognition for its potent inhibitor, PAWI-2, which shows promising results in targeting pancreatic cancer stem cells and synergizing with current standard of care. The company's commitment to innovation and collaboration is evident through its active engagement with partners, investors, and the scientific community. As a leading player in the field, ChemRegen continues to make significant contributions to the advancement of medical research and the development of novel therapies.
Generated from the website